Johnson & Johnson Presents New Nipocalimab Data And Real-World Research At AAN 2025 Highlighting Phase 3 Results And Commitment To People Living With Generalized Myasthenia Gravis
Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH
Amgen Options Trading: A Deep Dive Into Market Sentiment
Measles Cases Exceed 320 in Texas; DC Confirms Case in Amtrak
23andMe Bankruptcy Sparks Concerns Over Data Privacy
GSK to Investigate If Shingles Vaccine Can Cut Dementia Risk